Heron Therapeuti
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It … Read more
Heron Therapeuti (HRTX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.089x
Based on the latest financial reports, Heron Therapeuti (HRTX) has a cash flow conversion efficiency ratio of 0.089x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.33 Million) by net assets ($14.88 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Heron Therapeuti - Cash Flow Conversion Efficiency Trend (1989–2024)
This chart illustrates how Heron Therapeuti's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Heron Therapeuti Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Heron Therapeuti ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ChargePoint Holdings Inc
NYSE:CHPT
|
-0.586x |
|
Korea Environment Technology Co. LTD
KQ:029960
|
0.041x |
|
Salmon Evolution Holding AS
OL:SALME
|
-0.040x |
|
Castles Technology Co Ltd
TW:5258
|
0.010x |
|
Banque Cantonale Du Jura SA
SW:BCJ
|
-0.204x |
|
Beijing Tongtech Co Ltd
SHE:300379
|
-0.012x |
|
Econocom Group SA/NV
BR:ECONB
|
-0.130x |
|
Brunel International NV
AS:BRNL
|
0.153x |
Annual Cash Flow Conversion Efficiency for Heron Therapeuti (1989–2024)
The table below shows the annual cash flow conversion efficiency of Heron Therapeuti from 1989 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-33.65 Million | $-22.53 Million | 0.669x | -61.31% |
| 2023-12-31 | $-33.97 Million | $-58.79 Million | 1.730x | +115.99% |
| 2022-12-31 | $13.57 Million | $-146.91 Million | -10.825x | -312.91% |
| 2021-12-31 | $77.57 Million | $-203.35 Million | -2.622x | -235.45% |
| 2020-12-31 | $236.49 Million | $-184.82 Million | -0.782x | -153.33% |
| 2019-12-31 | $403.83 Million | $-124.58 Million | -0.308x | +40.46% |
| 2018-12-31 | $370.16 Million | $-191.81 Million | -0.518x | +60.10% |
| 2017-12-31 | $131.14 Million | $-170.30 Million | -1.299x | -120.58% |
| 2016-12-31 | $-21.25 Million | $-134.10 Million | 6.310x | +1049.10% |
| 2015-12-31 | $118.11 Million | $-78.53 Million | -0.665x | +30.45% |
| 2014-12-31 | $63.06 Million | $-60.28 Million | -0.956x | -61.68% |
| 2013-12-31 | $68.94 Million | $-40.76 Million | -0.591x | -80.12% |
| 2012-12-31 | $51.82 Million | $-17.01 Million | -0.328x | +33.03% |
| 2011-12-31 | $15.75 Million | $-7.72 Million | -0.490x | +88.24% |
| 2010-12-31 | $1.32 Million | $-5.48 Million | -4.166x | -157.43% |
| 2009-12-31 | $6.80 Million | $-11.00 Million | -1.618x | +49.34% |
| 2008-12-31 | $7.60 Million | $-24.27 Million | -3.195x | -444.92% |
| 2007-12-31 | $29.47 Million | $-17.28 Million | -0.586x | -177.01% |
| 2006-12-31 | $12.06 Million | $9.18 Million | 0.761x | +162.74% |
| 2005-12-31 | $6.20 Million | $-7.53 Million | -1.213x | -121.81% |
| 2004-12-31 | $14.15 Million | $-7.74 Million | -0.547x | +5.57% |
| 2003-12-31 | $11.26 Million | $-6.53 Million | -0.579x | -74.54% |
| 2002-12-31 | $15.46 Million | $-5.13 Million | -0.332x | +1.97% |
| 2001-12-31 | $19.17 Million | $-6.49 Million | -0.339x | -129.91% |
| 2000-12-31 | $21.16 Million | $-3.12 Million | -0.147x | -194.53% |
| 1999-12-31 | $12.00 Million | $-600.00K | -0.050x | +51.67% |
| 1998-12-31 | $14.50 Million | $-1.50 Million | -0.103x | -427.59% |
| 1997-12-31 | $10.20 Million | $-200.00K | -0.020x | +98.39% |
| 1996-12-31 | $5.00 Million | $-6.10 Million | -1.220x | +25.36% |
| 1995-12-31 | $5.20 Million | $-8.50 Million | -1.635x | -124.28% |
| 1994-12-31 | $11.80 Million | $-8.60 Million | -0.729x | +34.59% |
| 1993-12-31 | $10.50 Million | $-11.70 Million | -1.114x | -477.14% |
| 1992-12-31 | $20.20 Million | $-3.90 Million | -0.193x | +83.74% |
| 1991-12-31 | $3.20 Million | $-3.80 Million | -1.188x | -120.04% |
| 1990-12-31 | $6.30 Million | $-3.40 Million | -0.540x | -34.92% |
| 1989-12-31 | $9.50 Million | $-3.80 Million | -0.400x | -- |